Pfizer and BioNTech will supply the federal government with 100 million doses of coronavirus vaccine under a $1.95 billion deal, the biotech companies announced Wednesday. The agreement via the Trump administration’s Operation Warp Speed vaccination effort would allow the government to acquire an additional 500 million doses of the vaccine candidate, provided it has proved effective and secures regulatory approval.